Low expression of lncRNA APTR promotes gastric cancer progression

Aigang Ren,Qianqian Li,Yuntong Guo,Xiaolong Cui,Liwei Wang,Yaoliang Huo,Hao Chen,Hui Liu,He Huang,Aigang Ren,Qianqian Li,Yuntong Guo,Xiaolong Cui,Liwei Wang,Yaoliang Huo,Hao Chen,Hui Liu,He Huang

DOI: https://doi.org/10.1016/j.tranon.2022.101506

IF: 4.803

2022-11-01

Translational Oncology

Abstract:BackgroundGastric cancer (GC) is one of the most common cancers worldwide and the majority of GC patients are diagnosed at advanced stages due to the lack of early detection biomarkers. LncRNAs have been shown to play important roles in various diseases and could be predictive biomarkers and therapeutic targets. Our study demonstrated that low expression of lncRNA APTR could promote gastric cancer progression.MethodsDifferentiated expressed lncRNAs were identified through analyzing TCGA paired GC RNA sequencing data. LncRNA APTR's clinical relevance was analyzed using the TCGA dataset and GEO datasets. APTR expression in patient samples was detected through qPCR. The proliferation, colony formation, and migration of GC cells were tested. Bioinformatic analyses were performed to explore APTR-affected signaling pathways in GC.ResultsLncRNA APTR is lower expressed in gastric tumor samples and low expression of APTR predicts a poor diagnosis and outcome in GC patients. Silencing APTR promotes gastric cancer proliferation and invasiveness. APTR expression is negatively correlated with inflammatory signaling in the gastric tumor microenvironment.ConclusionOur study showed that low expression of lncRNA APTR in gastric cancer is correlated with tumorigenesis and poor diagnosis and prognosis, which is a potential biomarker for gastric cancer patients' diagnosis and treatment.

oncology